Thomas LeBlanc, MD, MA, MHS, FAAHPM, FASCO

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Menarini-Stemline
    Topic:
    Consulting, research, speaking
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Consulting, research
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novo Nordisk
    Topic:
    Events adjudication committee work for clinical trials
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Consulting, research
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Syndax
    Topic:
    Consulting
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Taiho
    Topic:
    Consulting, research
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Rigel
    Topic:
    Consulting, speaking
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Jazz
    Topic:
    research
    Date added:
    05/13/2025
    Date updated:
    05/13/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    UpToDate Inc.
    Topic:
    royalty for chapter on goals of care discussions
    Date added:
    05/13/2025
    Date updated:
    05/13/2025

Pages

Return to North Carolina Hematologic Malignancies Symposium